The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. AnaptysBio Inc shares valued at $72,270 were purchased by HOLLINGS C RENTON on Jun 18 ’25. At $23.97 per share, HOLLINGS C RENTON acquired 3,015 shares.
Also, DENNIS M FENTON purchased 3,015 shares, netting a total of over 72,270 in proceeds.
Before that, EcoR1 Capital, LLC had added 65,184 shares to its account. In a trade valued at $842,060, the Director bought AnaptysBio Inc shares for $12.92 each. Upon closing the transaction, the insider’s holdings increased to 65,184 shares, worth approximately $183.85 million.
As published in a research note from H.C. Wainwright on June 04, 2025, AnaptysBio Inc [ANAB] has been rated up from a Neutral to a Buy and the price target has been revised to $38. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in early February. As of December 11, 2024, H.C. Wainwright has decreased its “Buy” rating to a “Neutral” for ANAB. Earlier on December 02, 2024, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for ANAB stock which previously was a “a Buy”.
Analyzing ANAB Stock Performance
On last trading session,, AnaptysBio Inc [NASDAQ: ANAB] plunged -1.81% to $23.39. The stock’s lowest price that day was $23.025, but it reached a high of $24.09 in the same session. During the last five days, there has been a drop of approximately -0.89%. Over the course of the year, AnaptysBio Inc shares have jumped approximately 76.66%. Shares of the company reached a 52-week high of $24.68 on 06/04/25 and a 52-week low of $12.21 on 02/11/25.
Support And Resistance Levels for AnaptysBio Inc (ANAB)
According to the 24-hour chart, there is a support level at 22.89, which, if violated, would cause prices to drop to 22.38. In the upper region, resistance lies at 24.03. The next price resistance is at 24.67. RSI (Relative Strength Index) is 57.54 on the 14-day chart, showing neutral technical sentiment.
Is AnaptysBio Inc subject to short interest?
Stocks of AnaptysBio Inc saw a sharp rise in short interest on 2025-05-30 jumping by 0.25 million shares to 9.21 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 8.96 million shares. A jump of 2.68% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 16.72 of the overall float, the days-to-cover ratio (short ratio) jumped to 16.72.
Which companies own the most shares of AnaptysBio Inc (ANAB)?
In terms of AnaptysBio Inc share price expectations, FactSet research, analysts set an average price target of 39.5 in the next 12 months, up nearly 65.83% from the previous closing price of $23.82. Analysts anticipate AnaptysBio Inc stock to reach 54 by 2025, with the lowest price target being 25. In spite of this, 6 analysts ranked AnaptysBio Inc stock as Buy at the end of 2025. On July 22, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $55.
